ABMED · GLOBAL REGULATORY & MARKET ACCESS

European markets

38 international markets (countries and regional markets) in our service materials; each jurisdiction has its own requirements.

Find your target market

European Commission / national competent authorities

European Union

Market access overview

Apply MDR for general medical devices and IVDR for IVDs. Determine classification, conformity assessment, technical and clinical/performance evidence, EU-REP, PRRC and applicable UDI/EUDAMED obligations.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

MHRA

United Kingdom

Market access overview

Distinguish Great Britain from Northern Ireland. Check the eligible UKCA or recognised CE route, the UKRP and MHRA registration; registration is not itself comprehensive product approval.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Swissmedic

Switzerland

Market access overview

Swiss MedDO/IvDO requirements, applicable conformity evidence, CH-REP, importer responsibilities and swissdamed obligations are distinct from EU procedures.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

TİTCK

Türkiye

Market access overview

Confirm the Turkish device/IVD framework, the applicable local representative and establishment roles, Turkish information and ÜTS product and traceability requirements.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Based on the regulatory section of ABMED’s 38-market report, with source material dated 17 November 2026. Confirm current rules and the specific product before implementation. Market coverage does not imply a company office in every market.